COMMUNIQUÉS West-GlobeNewswire

MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
07/10/2026
Enrollment completed in Part C of THIO-101 Phase 2 study; 65% of 2026 enrollment target reached in pivotal THIO-104 Phase 3 study CHICAGO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA [...]
Byondis to Profile Potential of Platform Technologies at World ADC San Diego, Advancing Strategy to Lead the Antibody-Drug Conjugate Field
07/10/2026
Lead ADC candidate BYON14156 harnesses company’s first-in-class antifolate payload platform to overcome major payload resistance challenge seen in current and next-generation ADCs Advancement of IND-enabling package [...]
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing Methods
07/10/2026
As the FDA opens the door to non-animal safety testing, VivoSim's human-relevant models are already helping lower drug costs SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” [...]
Bexorg Awarded Up to $28.3 Million from ARPA-H to Advance Human Brain Translational Pharmacology for CNS Drug Development
07/10/2026
- Three-phase, 36-month award aims to extend BrainEx perfusion from 24 hours to up to two weeks, enabling longitudinal studies of human brain biology and therapeutic responses - NEW HAVEN, Conn., Oct. 07, 2026 (GLOBE [...]
AltruBio to Present Data from ALTB-268 Phase 2a Trial on Ulcerative Colitis at United European Gastroenterology (UEG) Week 2026
07/10/2026
SAN FRANCISCO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical-stage biotech company developing novel immune modulators to address the unmet need in immunological and [...]
Atsena Presents Positive Preliminary Safety and Efficacy Results from Parts A and B of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
07/10/2026
ATSN-201 demonstrated structural and functional benefit in Parts A and B, including microperimetry improvements exceeding the level the FDA has defined as supportive of potential approval Atsena also reported new data [...]
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
07/10/2026
REDWOOD CITY, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a clinical stage biotechnology company focused on the design and development of innovative [...]
Cerevance Announces Positive Phase 3 ARISE Results: Once-daily Oral Solengepras Meets Primary Endpoint and Demonstrates Motor and Non-motor Benefits in Parkinson's Disease
07/10/2026
Solengepras 150 mg achieved a statistically significant reduction in daily OFF time, with benefit seen at Week 2 Statistically significant improvements in secondary endpoints of ON time without troublesome dyskinesia [...]
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
07/10/2026
WALTHAM, Mass., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that [...]
Pacira BioSciences and Caregiver Action Network Announce New Survey on Gaps in Preparing Families for Postsurgical Recovery at Home
07/10/2026
Caregivers say they need clearer pain management plans, earlier education, and practical support on non-opioid options before a loved one undergoes surgery BRISBANE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Pacira [...]
Kyverna Therapeutics to Present Positive Data in Stiff Person Syndrome and Progressive Multiple Sclerosis at MSToronto2026
07/10/2026
Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and a well-tolerated safety profile with no high-grade CRS or ICANS and no [...]
Childhood cancer treatment success reaches 87%, says Medicana specialist
07/10/2026
Professor Tezer Kutluk points to six decades of progress and the growing role of personalised treatment, while warning that access to care still determines children’s chances ISTANBUL, Türkiye, Oct. 07, 2026 (GLOBE [...]
DCI Edge Introduces Series 5 Plus Dental Stools with 13° Anterior-Tilt Seat and Patent-Pending Brake
07/10/2026
New clinician's and assistant's stools, from DCI Edge, pair anti-slip Edge Upholstery with a 300 lb. capacity and a 10-year warranty. Newberg, OR, Oct. 07, 2026 (GLOBE NEWSWIRE) -- DCI Edge has released the Series 5 [...]
Vystar Announces Formation of New R3ALM Corporation and Progress Toward Live Platform Launch
07/10/2026
Company Advances R3ALM Ecosystem Toward Commercial Launch and Announces Multiple Tokenization Projects BOSTON, MA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST) today announced that, following the [...]
NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer
07/10/2026
NeOnc’s encouraging brain-cancer survival findings join developments from Revolution Medicines, Moderna and Merck, Johnson & Johnson, and Genmab and AbbVie. DENVER, Oct. 07, 2026 (GLOBE NEWSWIRE) -- ( www. [...]
AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays
07/10/2026
CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development Access the article here OCALA, Fla., Oct. 07, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech [...]
Optimi Health to Present at the ThinkEquity Conference
07/10/2026
VANCOUVER, British Columbia, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (FSE: 8BN) (“ Optimi ” or “the Company ”), a commercial-stage pharmaceutical manufacturer and clinical-stage [...]
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
07/10/2026
SUNNYVALE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
Integrity Care Group Enters Two New States and Strengthens Core Market with Acquisition of 15 NextCare Clinics; Now Offers Access to High-Quality Healthcare in 100 Clinics Across Five States
07/10/2026
The acquisition follows the recent unification of Xpress Wellness and Integrity Urgent Care under a single masterbrand – Integrity Care Group Key facts of this press release: Integrity Care Group acquired 15 NextCare [...]

Pages